-

Korian Invests in Start-Up Move in Med to Develop Coordinated Care Pathways

PARIS--(BUSINESS WIRE)--Regulatory News:

Korian (Paris:KORI), the leading European Care and Support Services Group for elderly and fragile people, has announced that it is in exclusive negotiations with the two co-founders of the start-up Move in Med with a view to acquiring a majority shareholding in the start-up’s share capital. Move in Med specialises in developing digital services and tools (e-health) to improve the care pathway of patients with chronic diseases. Awarded the Prix Galien in 2018, Move in Med is currently considered one of the most innovative companies in its field.

Move In Med offers specific expertise in consultancy, technological innovation and training for healthcare professionals and facilities. The care pathways it designs combine personalised support for patients with their own digital healthcare space, which centralises data and events relating to their healthcare pathway and facilitates interaction and cooperation between the medico-psycho-social healthcare professionals involved in their care.

“Korian shares a common vision with Move In Med of caring for chronic patients by improving the local doctor - hospital relationship on the one hand, and the patient experience on the other”, explains Nicolas Merigot, France Healthcare Division Executive VP.

Some 50 public, private, institutional and voluntary organisations already use Move In Med’s services. These include Korian, which worked with Move In Med to create an initial pathway, for patients suffering from chronic obstructive pulmonary disease (COPD), now operational in the Les Trois Tours clinic1 near Aix en Provence. Five further pathways are planned (patients fragility, post-stroke rehabilitation, Enhanced Recovery After Surgery (ERAS) in Orthopaedics, Outpatient Follow-up Care and Rehabilitation, Depression).

Korian also collaborated with Move in Med on its Oriane offer. “Move in Med enables digital technology to be used to help keep patients in their own home, as active participants in their own health, with prevention as the key focus”, comments Olivier Lebouché, Chief Executive Officer of Korian Domicile and Korian Solutions.

Founded in 2016 by Sylvie Boichot and Sohie Gendrault, scientists specialising in consultancy on technological innovation and coordinated care pathways, Move In Med currently employs 18 staff. The company aims to continue its development in France and internationally.

We are proud of this strategic partnership with the Korian Group, with whom we share the same values and beliefs. This will enable Move In Med to develop within an extremely favourable context, and allow patients to benefit from optimised, tailored care”, says Move In Med CEO, Sylvie Boichot.

Next publication: 27 February 2020 – Full-year revenue and results 2019 (after market close)

About Korian

Korian is the leading European Care and Support Services Group for elderly and fragile people. www.korian.com

Korian has been listed on Euronext Paris Section A since November 2006 and is included in the following indices: SBF 120, CAC Health Care, CAC Mid 60, CAC Mid & Small and MSCI Global Small Cap

Euronext Ticker: KORI - ISIN: FR0010386334 – Reuters: KORI.PA – Bloomberg: KORI.FP


1Post-acute and rehabilitation care facility specialising in respiratory diseases, located in La Destrousse.

Contacts

INVESTOR RELATIONS
Sarah Mingham
VP Investor Relations and Financing
sarah.mingham@korian.com
Tel: +33 (0)1 55 37 53 55

Carole Alexandre
Deputy Head of Investor Relations
carole.alexandre@korian.com
Tel: +33 (0)7 64 65 22 44

PRESS CONTACT
Marjorie Castoriadis
Head of Media Relations
marjorie.castoriadis@korian.fr
Tel: +33 (0)7 63 59 88 81

Korian

BOURSE:KORI

Release Versions

Contacts

INVESTOR RELATIONS
Sarah Mingham
VP Investor Relations and Financing
sarah.mingham@korian.com
Tel: +33 (0)1 55 37 53 55

Carole Alexandre
Deputy Head of Investor Relations
carole.alexandre@korian.com
Tel: +33 (0)7 64 65 22 44

PRESS CONTACT
Marjorie Castoriadis
Head of Media Relations
marjorie.castoriadis@korian.fr
Tel: +33 (0)7 63 59 88 81

More News From Korian

Clariane: Availability and Consultation of the Information Relating to the Combined General Meeting to Be Held on 14 May 2025

PARIS--(BUSINESS WIRE)--Regulatory News: Clariane (CLARI.PA - ISIN: FR0010386334) informs its shareholders that a Combined General Meeting (the "General Meeting") of the Company will take place on Wednesday 14 May 2025 at 2 p.m. in the meeting room Apostrophe, located at 83 avenue Marceau, 75016 Paris. The prior notice of the General Meeting containing the agenda, the draft resolutions presented by the Board of Directors and the description of the participation and voting arrangements for the G...

Clariane: Information on the Availability of the 2024 Universal Registration Document

PARIS--(BUSINESS WIRE)--Regulatory News: Clariane (CLARI.PA - ISIN: FR0010386334) announces the release of its 2024 Universal Registration Document. The 2024 Universal Registration Document was filed with the French Financial Markets Authority on 31 March 2025 in ESEF format, under number D.25-0209. This 2024 Universal Registration Document, established for the financial year ended on 31 December 2024, includes in particular: - the annual financial report and the integrated report, - the report...

Clariane: Governance Evolution - Mrs Sylvia Metayer, Independent Director, Appointed Chairwoman of the Board of Directors With Effect From May 14th, 2025

PARIS--(BUSINESS WIRE)--Regulatory News: Clariane (CLARI.PA - ISIN: FR0010386334) today announces a change in its corporate governance, with the appointment of Sylvia Metayer, an independent director, as Chairwoman of the Board of Directors at the close of the Annual General Meeting on 14 May 2025. Jean-Pierre Duprieu having indicated that he did not wish to be reappointed as Director at the Annual General Meeting of 14 May 2025, in anticipation of the statutory age limit of 75, the Board of Di...
Back to Newsroom